{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:00:55Z","timestamp":1780624855658,"version":"3.54.1"},"reference-count":12,"publisher":"Walter de Gruyter GmbH","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jom-2025-0053_abs_001\">\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Ehlers-Danlos syndrome (EDS) and hypermobility spectrum disorder (HSD) are connective tissue disorders associated with musculoskeletal manifestations and significant psychiatric comorbidities. Psychoactive medications commonly utilized in these populations raise concerns regarding potential cardiac effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jom-2025-0053_abs_002\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study explores associations between psychoactive medication utilization and electrocardiogram (ECG) parameters in patients with hypermobile Ehlers-Danlos syndrome (hEDS) and HSD to provide insight into potential cardiac considerations in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jom-2025-0053_abs_003\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective analysis included de-identified data from patients referred for cardiac evaluation at the Long Island Heart Rhythm Center between January 2019 and June 2023. Diagnosis of EDS and HSD were made utilizing the 2017 International Classification criteria. Psychiatric diagnoses were classified per DSM-5 criteria, and psychoactive medications were categorized utilizing NIH guidelines. ECG parameters, psychiatric diagnoses, and psychoactive medication use were compared between groups. Statistical analyses included Student\u2019s t-tests for continuous variables, chi-square or Fisher\u2019s exact tests for categorical variables, and odds ratio (OR) calculations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jom-2025-0053_abs_004\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 109 patients (hEDS: n=75; HSD: n=34), psychiatric diagnoses were more prevalent in hEDS patients (72 vs. 38.2\u202f%; p=0.008), with significant differences in trauma- and stressor-related disorders (p=0.009) and ADHD (p=0.006). hEDS patients had a higher mean psychoactive medication use (1.8 vs. 1.1; p=0.019) and greater anticonvulsant use (33.3 vs. 8.8\u202f%; p=0.008). In a subset with ECG data (n=62), QTc intervals were significantly shorter in hEDS patients (421.62\u00a0\u00b1\u00a022.47\u202fms vs. 436.73\u00a0\u00b1\u00a018.74\u202fms; p=0.022), yet within normal ranges. QTc prolongation was more frequent in HSD patients (26.7 vs. 6.4\u202f%; OR 5.33; 95\u202f% confidence interval (CI) [1.04\u201327.39]; p=0.045).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jom-2025-0053_abs_005\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>hEDS patients had a higher psychiatric burden and psychoactive medication use than HSD patients, but ECG parameters largely remained within normal limits. The increased QTc prolongation in HSD patients highlights potential cardiovascular risks, requiring further investigation. Routine cardiovascular monitoring and interdisciplinary care are recommended for hypermobile patients on psychoactive medications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jom-2025-0053","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:24:01Z","timestamp":1780622641000},"source":"Crossref","is-referenced-by-count":0,"title":["Psychoactive medication use and cardiac electrophysiology in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder: a retrospective analysis"],"prefix":"10.1515","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8673-9871","authenticated-orcid":false,"given":"Riya","family":"Kaushal","sequence":"first","affiliation":[{"name":"New York Institute of Technology College of Osteopathic Medicine , Old Westbury , NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Snyder","sequence":"additional","affiliation":[{"name":"New York Institute of Technology College of Osteopathic Medicine , Old Westbury , NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9245-6168","authenticated-orcid":false,"given":"Ermin","family":"Tale","sequence":"additional","affiliation":[{"name":"New York Institute of Technology College of Osteopathic Medicine , Old Westbury , NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat","family":"Jarkon","sequence":"additional","affiliation":[{"name":"Department of Family Medicine , New York Institute of Technology College of Osteopathic Medicine , Old Westbury , NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Riley","sequence":"additional","affiliation":[{"name":"Department of Clinical Specialties , New York Institute of Technology College of Osteopathic Medicine , Old Westbury , NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd J.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Clinical Specialties , New York Institute of Technology College of Osteopathic Medicine , Old Westbury , NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"2026060501235761401_j_jom-2025-0053_ref_001","doi-asserted-by":"crossref","unstructured":"Hershenfeld, SA, Wasim, S, McNiven, V, Parikh, M, Majewski, P, Faghfoury, H, et al.. Psychiatric disorders in Ehlers-Danlos syndrome are frequent, diverse, and strongly associated with pain. Rheumatol Int 2016;36:341\u20138. https:\/\/doi.org\/10.1007\/s00296-015-3375-1.","DOI":"10.1007\/s00296-015-3375-1"},{"key":"2026060501235761401_j_jom-2025-0053_ref_002","doi-asserted-by":"crossref","unstructured":"Ishiguro, H, Yagasaki, H, Horiuchi, Y. Ehlers-danlos syndrome in the field of psychiatry: a review. Front Psychiatr 2022;12. https:\/\/doi.org\/10.3389\/fpsyt.2021.803898.","DOI":"10.3389\/fpsyt.2021.803898"},{"key":"2026060501235761401_j_jom-2025-0053_ref_003","doi-asserted-by":"crossref","unstructured":"de Vries, J, Verbunt, J, Stubbe, J, Visser, B, Ramaekers, S, Calders, P, et al.. Generalized joint hypermobility and anxiety in adolescents and young adults: the impact on physical and psychosocial functioning. Healthcare 2021;9:525. https:\/\/doi.org\/10.3390\/healthcare9050525.","DOI":"10.3390\/healthcare9050525"},{"key":"2026060501235761401_j_jom-2025-0053_ref_004","doi-asserted-by":"crossref","unstructured":"Rashed, ER, Ruiz Maya, T, Black, J, Fettig, V, Kadian-Dodov, D, Olin, JW, et al.. Cardiovascular manifestations of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Vasc Med 2022;27:283\u20139. https:\/\/doi.org\/10.1007\/s00296-019-04293-w.","DOI":"10.1177\/1358863X211067566"},{"key":"2026060501235761401_j_jom-2025-0053_ref_005","doi-asserted-by":"crossref","unstructured":"Brooks, RS, Grady, J, Lowder, TW, Blitshteyn, S. Prevalence of gastrointestinal, cardiovascular, autonomic, and allergic manifestations in hospitalized patients with Ehlers-Danlos syndrome: a case-control study. Rheumatology 2021;60:4272\u201380. https:\/\/doi.org\/10.1093\/rheumatology\/keaa926.","DOI":"10.1093\/rheumatology\/keaa926"},{"key":"2026060501235761401_j_jom-2025-0053_ref_006","doi-asserted-by":"crossref","unstructured":"Knight, DRT, Bruno, KA, Singh, A, Munipalli, B, Gajarawala, S, Solomon, M, et al.. Cardiac defects of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: a retrospective cohort study. Front Cardiovasc Med 2024;11:1332508. https:\/\/doi.org\/10.3389\/fcvm.2024.1332508.","DOI":"10.3389\/fcvm.2024.1332508"},{"key":"2026060501235761401_j_jom-2025-0053_ref_007","doi-asserted-by":"crossref","unstructured":"Malfait, F, Francomano, C, Byers, P, Belmont, J, Berglund, B, Black, J, et al.. The 2017 international classification of the ehlers-danlos syndromes. Am J Med Genet C Semin Med Genet 2017;175:8\u201326. https:\/\/doi.org\/10.1002\/ajmg.c.31552.","DOI":"10.1002\/ajmg.c.31552"},{"key":"2026060501235761401_j_jom-2025-0053_ref_008","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. Washington, DC: American Psychiatric Association; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"2026060501235761401_j_jom-2025-0053_ref_009","unstructured":"NIH National Library of Medicine. MedlinePlus. https:\/\/medlineplus.gov\/ [Accessed 20 June 2023]."},{"key":"2026060501235761401_j_jom-2025-0053_ref_010","doi-asserted-by":"crossref","unstructured":"Salama, G, Bett, GC. Sex differences in the mechanisms underlying long QT syndrome. Am J Physiol Heart Circ Physiol 2014;307:H640\u20138. https:\/\/doi.org\/10.1152\/ajpheart.00864.2013.","DOI":"10.1152\/ajpheart.00864.2013"},{"key":"2026060501235761401_j_jom-2025-0053_ref_011","doi-asserted-by":"crossref","unstructured":"Wasim, S, Suddaby, JS, Parikh, M, Leylachian, S, Ho, B, Guerin, A, et al.. Pain and gastrointestinal dysfunction are significant associations with psychiatric disorders in patients with Ehlers-Danlos syndrome and hypermobility spectrum disorders: a retrospective study. Rheumatol Int 2019;39:1241\u20138. https:\/\/doi.org\/10.1007\/s00296-019-04293-w.","DOI":"10.1007\/s00296-019-04293-w"},{"key":"2026060501235761401_j_jom-2025-0053_ref_012","doi-asserted-by":"crossref","unstructured":"Darakjian, AA, Bhutani, M, Fairweather, D, Kocsis, SC, Fliess, JJ, Khatib, S, et al.. Similarities and differences in self-reported symptoms and comorbidities between hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Rheumatol Adv Pract 2024;8:rkae134. https:\/\/doi.org\/10.1093\/rap\/rkae134.","DOI":"10.1093\/rap\/rkae134"}],"container-title":["Journal of Osteopathic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jom-2025-0053\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jom-2025-0053\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:24:10Z","timestamp":1780622650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jom-2025-0053\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":12,"alternative-id":["10.1515\/jom-2025-0053"],"URL":"https:\/\/doi.org\/10.1515\/jom-2025-0053","relation":{},"ISSN":["2702-3648"],"issn-type":[{"value":"2702-3648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]}}}